# Stemirna Therapeutics Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/stemirna-therapeutics-co

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Website: www.stemirna.com
- Latest round: Series A (Jul 1, 2019)
- Investors on record: 5

## About

Based in Shanghai, China, and established in 2016, Stemirna Therapeutics Co., Ltd. is a biotechnology company that specializes in mRNA technology. Li Hangwen is the founder and current CEO of the company. It has partnerships with Baidu USA Research Institute, Oregon State University, and the University of Rochester. Following the venture funding in June 2021, the company plans to use the proceeds to finance clinical trials and the production of its COVID-19 vaccine candidate. In May 2023, t raised an undisclosed amount of pre-series D funding from other unspecified investors. The company has 50,000 square meters of vaccine production base and 400 million doses of vaccine capacity as of 2023.

The company focuses on developing and providing mRNA (mRNA stands for messenger RNA, it is the information carrier in the process of gene expression) drugs for different diseases, including cancer, contagion, and a genetic disorder. The company's platforms include an mRNA synthesis platform, an LPP (ipopolyplex) delivery platform, and GMP manufacturing (GMP-compliant facilities for manufacturing and quality control). The company has also developed a pipeline that spans different therapeutic areas, including immuno-oncology, infectious diseases, and iPSC, based on its mRNA synthesis platform and LPP delivery platform.

## Funding rounds

- Series A, Jul 1, 2019 — Lapam Capital, Zhuhai Longmen Capital Management, Jiuyo Capital, Shanghai Zhangjiang Torch Innovation Park Investment and Development
- Series A, Jun 11, 2018 — Lapam Capital, Puhong Capital

## Investors

- Lapam Capital (https://capitalatlas.ai/funds/lapam-capital) — Series A
- Puhong Capital (https://capitalatlas.ai/funds/puhong-capital) — Series A
- Zhuhai Longmen Capital Management (https://capitalatlas.ai/funds/zhuhai-longmen-capital-management) — Series A
- Jiuyo Capital (https://capitalatlas.ai/funds/jiuyo-capital) — Series A
- Shanghai Zhangjiang Torch Innovation Park Investment and Development — Series A